Hippo Signaling Transduction Pathway Deregulation in Eye Diseases
Hippo deregulation is critically involved in retina- and lens-related benign lesions as well as in conjunctival fibrosis and ocular surface squamous neoplasia. YAP/TEAD point mutations and abnormal expression of other molecules are the main genetic mechanisms in these lesions.
Authors
- Angelos Liontos (ORCID: https://orcid.org/0000-0002-0361-0846)
- Alexandros Tsantoulas
- Panagiotis Fotiades
- Athanasios Niotis
- Chrissa Sioka (ORCID: https://orcid.org/0000-0002-2184-4945)
- Vasileios Ragos (ORCID: https://orcid.org/0000-0002-0523-0476)
- Christos Kalogeropoulos (ORCID: https://orcid.org/0000-0001-6908-0924)
- SOTIRIOS PAPOULIAKOS
- Evangelos Tsiambas (ORCID: https://orcid.org/0000-0001-5541-2465)
- Georgios Papanastasiou
- Napoleon-Georgios Ragkos
- Kyriakos Gklezakos
Institutions
- University of Ioannina (GR)
- European University Cyprus (CY)
- General Hospital of Athens G. Genimatas (GR)
- NIMTS Hospital (GR)
- 424 General Military Hospital (GR)
- KAT General Hospital of Attica (GR)
Publication Details
- Journal
- MAEDICA – a Journal of Clinical Medicine
- Published
- 2025-09-15
- DOI
- https://doi.org/10.26574/maedica.2025.20.3.610
- Primary Topic
- Hippo pathway signaling and YAP/TAZ
- Type
- article
- Field-Weighted Citation Impact
- 0.00